ReleaseWire

SHARE Cancer Support, a nonprofit offering free support to women with breast and ovarian cancer, is partnering with Chef Melba Wilson of Melba's Restaurant to offer free mammograms to women.

SHARE Cancer Support, a nonprofit offering free support to women with breast and ovarian cancers, is partnering with Chef Melba Wilson of Melba's Restaurant to offer free mammograms to women.

ProLung, Inc., ("ProLung" or the "Company") the world leader in innovative predictive analytics technology and non-invasive tests for the risk stratification of lung cancer, announces today the appointment of Kristin M. Larson, NP, to Director of Clinical Affairs.

Mr. Jerry Remy, the well-recognized broadcast voice of the Boston Red Sox, is a five-time lung cancer survivor. In an interview conducted by ProLung, Inc. ("ProLung" or the "Company"), Mr. Remy and his wife, Phoebe, urge those at risk of lung cancer "to get to their doctor."

Purple Wishing Gate, a provider of unique and religious blessing gifts, has chosen the Candlelighters Childhood Cancer Foundation of Delaware (CCCFD) as the charity they will be donating to this year. Each year, Purple Wishing Gate selects one organization to donate a portion of all proceeds. The CCCFD was chosen based on Facebook votes and input from the company's founder, Barbara D. MacAdam.

ProLung, Inc., ("ProLung" or the "Company") the world leader in innovative predictive analytics technology and non-invasive tests for the risk stratification of lung cancer, announces that the company has promoted Andy C. Robertson to Chief Marketing Officer.

Cancer vaccines are being developed as a method of preventing certain types of cancer, and as therapeutic treatments to treat existing cancers across a range of indications in oncology, either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. The high mortality rate associated with cancer and its resistance to conventional treatments such as radiation and chemotherapy has led to the investigation of a variety of anti-cancer immunotherapies, which have a lower toxicity associated with their use than traditional chemotherapies.

On March 3, Triple Negative Awareness Day, SHARE Cancer Support, a national breast and ovarian cancer support nonprofit, is raising awareness about triple negative breast cancer to help the public understand the risks and severity of developing the disease and to encourage advocacy efforts for better treatments.

BriaCell Therapeutics Corp.("BriaCell"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce the opening of a new clinical site, Jefferson Breast Care Center in Philadelphia, PA, and the appointment of Dr. Saveri Bhattacharya, a board certified medical oncologist, as the clinical site's principal investigator. Dr. Bhattacharya will work closely with Cancer Insight, LLC., BriaCell's contract research organization, to manage the clinical and regulatory aspects of the clinical trial on behalf of BriaCell.

Anthony B. Miller MD, a longtime advisor to the World Health Organization and senior advisor to Environmental Health Trust (EHT) has issued a statement that the recently released findings from the $25M NIH/NIEHS National Toxicology Program (NTP) cell phone radiofrequency radiation carcinogenicity studies combined with human epidemiology studies "conclusively confirms that radiofrequency radiation is a category 1 human carcinogen." EHT is a scientific think tank focused on preventable environmental health risks and will be publishing a series of expert reactions to the NTP technical reports this week.

The National Toxicology Program (NTP) division of the National Institutes of Environmental Health Sciences (NIEHS) is releasing the full results of its multi-year study on mice and rats exposed to cell phone radiation today at noon EST.

Recently, the Lauren Ashtyn Collection launched a number of charitable and promotional initiatives on its website to fight breast cancer. Users and customers were offered prizes as incentives to discuss breast cancer experiences and the firm also donated a share of its sales revenue to the Susan G. Komen South Carolina.

On January 27, 2018, Dr. Patrick Hsu and Dr. Kendall Roehl, together with Memorial Plastic Surgery's staff and patients, are encouraging everyone to join them for the Susan G. Komen Race for the Cure® at the Sam Houston Park in Downtown Houston.

New Jersey drivers who are looking for a way to start their year off by giving back to the community are encouraged to contact American Children's Society, Inc. to learn more about how they can turn an old vehicle into a way to help children suffering from cancer and other life-threatening illnesses.

TriForce CrossFit is officially opening its doors on Thursday, January 4th and welcoming anyone in the community to stop by and help row for cancer. For every 1k rowed during the grand opening between 9 a.m. and 8 p.m. $1 will be donated to Lynch Syndrome International toward helping to fight cancer.

CEL-SCI Corporation announced today that healthcare information technology executive Robert Watson has joined the Company's Board of Directors.

Top line results may soon be in at CEL-SCI, which concluded patient enrollment and dosing in the world's largest Phase III trial in the treatment of head and neck cancer. Between 2011 and 2016, 928 patients were enrolled and treated. According to the study's protocol, the effectiveness of CEL-SCI's drug in prolonging life can only be judged after 298 of the enrolled patients have died, since the FDA wants to see survival benefit. The number of deaths, or 'events', as they are termed in clinical trials, is unfortunately how and when the primary endpoint of most cancer studies are determined.

CEL-SCI Corporation announced today that no further patient enrollment is required in the pivotal Phase 3 head and neck cancer study of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). The accrual and treatment phases of this Phase 3 study are complete. All of the 928 enrolled patients in the study are being followed-up as required by the study protocol.

According to the American Cancer Society, an estimated 1,688,780 new cancer cases and 600,920 cancer deaths will occur in the US this year. According to the US Small Business Administration, 9% of the US population are small business owners and entrepreneurs. That means over 150,000 small business owners will be diagnosed with cancer, and more than 50,000 won't survive, leaving their families, employees, and customers behind.

From the perspective of a stage IV cancer survivor and his caregiver, this is a detailed self-help journal on how to live calmly with cancer by using mindfulness and meditation. Married couple Tamara Green and David Dachinger have released an inspiring book documenting how they found inner peace in spite of their many challenges during David's diagnosis and treatment for metastatic cancer. The book provides quick and easy mindfulness tools and powerful meditations that help ease depression, anxiety and overwhelm.

This Christmas is unlike any previous one for LANGRIA. The furniture brand wants to give back and donate to Children's Cancer Research Fund to put a smile on kid's that are affected by any form of childhood cancer.

ImageFIRST, a provider of medical scrubs and uniforms in Cedar Rapids, IA, and throughout the continental United States and Puerto Rico, promoted breast cancer awareness during the month of October. At ImageFIRST's Los Angeles and San Francisco locations, associates showed their support for Breast Cancer Awareness Month a number of different ways.

Throughout the month of October, associates at several ImageFIRST branches showed their support for Breast Cancer Awareness Month in a variety of ways. ImageFIRST is a provider of medical laundry services in Cleveland, OH and across the continental United States and Puerto Rico.

Ulterra Drilling Technologies is a Fort Worth based PDC Bit Company known for their iconic teal bits. For the past 4 years, Ulterra has been committed to spreading awareness within the oilfield by collaborating with the organization Saving True Pairs based in Midland, TX. Their mission is to raise awareness of women's health issues and foster educational and service initiatives that positively embrace women's health. In Midland County alone 4 out of 5 women over 40 do not get mammograms. This is a big concern and the reasoning behind the organization's motivation to raise funds and awareness.

BriaCell Therapeutics Corp. ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary vaccine technology, today released a clinical update on its ongoing Phase I/IIa study of its lead vaccine candidate, BriaVax™, in advanced breast cancer patients.